| Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later AM Ryan, DG Power, L Daly, SJ Cushen, ĒN Bhuachalla, CM Prado Proceedings of the Nutrition Society 75 (2), 199-211, 2016 | 522 | 2016 |
| The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme RM Bambury, MY Teo, DG Power, A Yusuf, S Murray, JE Battley, C Drake, ... Journal of neuro-oncology 114 (1), 149-154, 2013 | 199 | 2013 |
| Advanced gastric cancer–slow but steady progress DG Power, DP Kelsen, MA Shah Cancer treatment reviews 36 (5), 384-392, 2010 | 196 | 2010 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study G James, A Adesoji, A Adewale, A Ehab, PA Alexis, A Faris, M Ana, ... | 186 | 2021 |
| Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets AM Ryan, M Duong, L Healy, SA Ryan, N Parekh, JV Reynolds, ... Cancer epidemiology 35 (4), 309-319, 2011 | 182 | 2011 |
| Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer LE Daly, EB Ni Bhuachalla, DG Power, SJ Cushen, K James, AM Ryan Journal of cachexia, sarcopenia and muscle 9 (2), 315-325, 2018 | 167 | 2018 |
| The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma LE Daly, DG Power, Á O'Reilly, P Donnellan, SJ Cushen, K O'Sullivan, ... British journal of cancer 116 (3), 310-317, 2017 | 156 | 2017 |
| Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state AM Ryan, LA Healy, DG Power, M Byrne, S Murphy, PJ Byrne, D Kelleher, ... Annals of surgery 247 (6), 909-915, 2008 | 128 | 2008 |
| Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival AM Ryan, CM Prado, ES Sullivan, DG Power, LE Daly Nutrition 67, 110539, 2019 | 125 | 2019 |
| Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer DG Power, MA Schattner, H Gerdes, B Brenner, AJ Markowitz, M Capanu, ... Journal of the American College of Surgeons 208 (2), 173-178, 2009 | 125 | 2009 |
| 173 Endoscopic Ultrasound Can Improve the Selection for Laparoscopy in Patients with Localized Gastric Cancer DG Power, MA Schattner, H Gerdes, B Brenner, AJ Markowitz, M Capanu, ... | 125* | |
| Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib SJ Cushen, DG Power, MY Teo, P MacEneaney, MM Maher, R McDermott, ... American journal of clinical oncology 40 (1), 47-52, 2017 | 101 | 2017 |
| Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition? ÉB Ní Bhuachalla, LE Daly, DG Power, SJ Cushen, P MacEneaney, ... Journal of cachexia, sarcopenia and muscle 9 (2), 295-305, 2018 | 100 | 2018 |
| Role of adjuvant therapy after resection of colorectal cancer liver metastases DG Power, NE Kemeny Journal of clinical oncology 28 (13), 2300-2309, 2010 | 99 | 2010 |
| Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel SJ Cushen, DG Power, KP Murphy, R McDermott, BT Griffin, M Lim, ... Clinical nutrition ESPEN 13, e39-e45, 2016 | 93 | 2016 |
| Short-term nutritional implications of total gastrectomy for malignancy, and the impact of parenteral nutritional support AM Ryan, LA Healy, DG Power, SP Rowley, JV Reynolds Clinical nutrition 26 (6), 718-727, 2007 | 87 | 2007 |
| The role of floxuridine in metastatic liver disease DG Power, NE Kemeny Molecular cancer therapeutics 8 (5), 1015-1025, 2009 | 86 | 2009 |
| New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment KP Murphy, MP Kennedy, JE Barry, KN O'Regan, DG Power Oncology research and treatment 37 (6), 351-353, 2014 | 81 | 2014 |
| Poor awareness of risk factors for cancer in Irish adults: results of a large survey and review of the literature AM Ryan, S Cushen, H Schellekens, EN Bhuachalla, L Burns, U Kenny, ... The oncologist 20 (4), 372, 2015 | 71 | 2015 |
| A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma MA Shah, DG Power, HL Kindler, KD Holen, MM Kemeny, DH Ilson, ... Investigational new drugs 29 (6), 1475-1481, 2011 | 71 | 2011 |
